Disclosures
Information for prescribers as required by Connecticut Pub. Act No. 23‑171 and Colorado Revised Statutes 12‑280‑308
The wholesale acquisition cost (or WAC), also known as list price, is established by Intra-Cellular Therapies, Inc. which may not reflect the price paid by patients or insurers. Patients with insurance may pay less than the WAC price.
- The WAC per CAPLYTA 42 mg capsule is $55.39*
- The WAC per CAPLYTA 21 mg capsule is $55.39*
- The WAC per CAPLYTA 10.5 mg capsule is $55.39*
However, eligible commercially insured patients may pay as little as $0 for their first two fills up to a 30-day supply, and $15 for subsequent fills up to a 90-day supply of CAPLYTA.† Please click here for full Eligibility Criteria and Terms & Conditions.
Below, please find three generic prescription drug examples within the atypical antipsychotic class:
- Risperidone
- Olanzapine
- Clozapine
Variation Efficacy
Examination of racial and ethnic subgroups in the clinical studies did not suggest differences in efficacy for CAPLYTA between these subgroups.
*Source: AnalySource® 01/01/2024 as reprinted with permission by First Databank, Inc. All rights reserved. ©2024
†This offer is valid for eligible new or existing patients who are filling a prescription for CAPLYTA. Eligible patients must be 18 years of age or older, residents of the U.S., excluding Puerto Rico and have a valid prescription for CAPLYTA for a Food & Drug Administration approved indication. This Savings program is valid ONLY for patients with private commercial insurance and NOT valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs. Offer is only good at participating retail pharmacies. Offer is not transferable, is not insurance, has no cash value, and may not be used in combination with other offers. Void if prohibited by law, taxed or restricted.
All participants are responsible for reporting the receipt of all Program benefits as required by their insurance provider. No party may seek reimbursement for all or any of the benefit received through this Program. Intra-Cellular Therapies reserves the right to rescind, revoke or amend the Program without notice at any time. Additional eligibility criteria apply. Click here for full Eligibility Criteria and Terms & Conditions.